53 results match your criteria: "U.S. National Cancer Institute[Affiliation]"
Turk J Gastroenterol
January 2018
Department of Epidemiology, University of California Irvine, USA.
Background/aims: There are wide variations in colorectal cancer (CRC) incidence across the world. Historically, the highest incidence rates have been reported historically in more developed countries; however, increasing trends have been seen in developing countries. Here, we present the CRC incidence pattern in Cyprus, Israel, Jordan, and İzmir, Turkey, which are countries of the Middle East Cancer Consortium (MECC).
View Article and Find Full Text PDFPLoS One
January 2018
Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Introduction: Sex hormones have been implicated in the etiology of a number of diseases. To better understand disease etiology and the mechanisms of disease-risk factor associations, this analysis aimed to investigate the associations of anthropometric, sociodemographic and behavioural factors with a range of circulating sex hormones and sex hormone-binding globulin.
Methods: Statistical analyses of individual participant data from 12,330 male controls aged 25-85 years from 25 studies involved in the Endogenous Hormones Nutritional Biomarkers and Prostate Cancer Collaborative Group.
J Cancer Policy
June 2017
U.S. National Cancer Institute, Center for Global Health, 9609 Medical Center Drive, Room 3W260, Rockville, MD 20850 USA.
Radiat Environ Biophys
May 2017
HMGU Institute of Radiation Protection, Neuherberg, Germany.
Eur J Cancer
October 2016
Centre for Cancer Epidemiology, Tata Memorial Centre, Mumbai, 400 012, India. Electronic address:
Background: Current evidence suggests that the relationship between obesity and breast cancer (BC) risk may vary between ethnic groups.
Methods: A total of 1633 BC cases and 1504 controls were enrolled in hospital-based case-control study in Mumbai, India, from 2009 to 2013. Along with detailed questionnaire, we collected anthropometric measurements on all participants.
J Natl Cancer Inst
December 2016
SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA (JMU, CT, CMT, PJG, WEB); Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX (IMTJr); Columbia University, New York, NY (JDW, DLH); Fred Hutchinson Cancer Research Center, Seattle, WA (SDR); Division of Cancer Prevention, U.S. National Cancer Institute, Rockville, MD (LMM).
Background: Finasteride has been found to reduce the risk of low-grade prostate cancer but to have no impact on overall survival. The long-term adverse and beneficial consequences of finasteride have not been examined.
Methods: We used a linkage between data from the Prostate Cancer Prevention Trial (PCPT) and Medicare claims.
Sci Transl Med
June 2016
Syril D. Pettit is the Executive Director of the ILSI, Health and Environmental Sciences Institute (HESI), Washington, DC 20005, USA. Email: E. Lipshultz is Pediatrician-in-Chief of Children's Hospital of Michigan; Chair of Pediatrics, Wayne State University School of Medicine; President of University Pediatricians; and Interim Director of Children's Research Center of Michigan, Detroit, MI 48201, USA; and Editor-in-Chief, Cardio-Oncology.Charles S. Cleeland is McCullough Professor of Cancer Research, Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.Samantha Roberts is Director of Scientific Affairs, Friends of Cancer Research, Washington, DC 20036, USA.Myrtle Davis is Chief, Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute, Bethesda, MD 20892, USA.Brian R. Berridge is Senior GSK Fellow and Head of Worldwide Animal Research Strategy, GlaxoSmithKline, King of Prussia, PA 19406, USA.Rebecca A. Kirch is Executive Vice President, Healthcare Quality and Value, National Patient Advocate Foundation, Washington, DC 20005, USA.
Translational cancer research requires a quality-of-life-driven agenda.
View Article and Find Full Text PDFInt J Cancer
October 2016
Division of Cancer Epidemiology and Genetics, U.S. National Cancer Institute, Bethesda, MD.
Multiple myeloma (MM) has been consistently linked with agricultural activities, including farming and pesticide exposures. Three case-control studies in the United States and Canada were pooled to create the North American Pooled Project (NAPP) to investigate associations between pesticide use and haematological cancer risk. This analysis used data from 547 MM cases and 2700 controls.
View Article and Find Full Text PDFScience
April 2016
Harold Varmus is the Lewis Thomas University Professor at the Meyer Cancer Center, Weill Cornell Medicine, New York, NY; Senior Associate Member of the New York Genome Center, New York, NY; and former director of the U.S. National Cancer Institute.
J Cancer Policy
March 2016
U.S. National Cancer Institute, Center for Global Health.
Background: Cancer is the third leading cause of mortality in Kenya, accounting for 7% of annual deaths. The Kenyan Ministry of Health (MOH) is committed to reducing cancer mortality, as evidenced by policies such as the National Cancer Control Strategy (2011-2016). There are many Kenyan and international organizations devoted to this task; however, coordination is lacking among stakeholders, resulting in inefficient and overlapping expenditure of resources.
View Article and Find Full Text PDFCancer Res
April 2016
Clinical Trials Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
The role of insulin-like growth factors (IGF) in prostate cancer development is not fully understood. To investigate the association between circulating concentrations of IGFs (IGF-I, IGF-II, IGFBP-1, IGFBP-2, and IGFBP-3) and prostate cancer risk, we pooled individual participant data from 17 prospective and two cross-sectional studies, including up to 10,554 prostate cancer cases and 13,618 control participants. Conditional logistic regression was used to estimate the ORs for prostate cancer based on the study-specific fifth of each analyte.
View Article and Find Full Text PDFHealth Phys
January 2016
*Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 9609 Medical Center Drive, Bethesda, MD 20892; †United Institute of Informatics Problems, Minsk, Belarus; ‡Research Institute for Nuclear Problems, Minsk, Belarus; §U.S. National Cancer Institute (retired).
Interviews with questionnaires are often employed to provide information that may be used for exposure assessment, although the reliability of such information is largely unknown. In this work, the consistency of individual behavior and dietary data collected by means of personal interviews during two study screenings was evaluated. Data were collected for a cohort of about 11,000 persons exposed to 131I in childhood and adolescence shortly after the Chernobyl accident.
View Article and Find Full Text PDFCancer Causes Control
February 2016
Centre for Cancer Epidemiology, Tata Memorial Centre, E. Borges Road, Parel Mumbai, Maharashtra, 400 012, India.
Purpose: Although cancer registry data indicate that there are large differences in breast cancer (BC) rates between rural and urban regions of India, the reasons for these differences are not well understood.
Methods: We conducted a hospital based case-control study (1,637 breast cancer cases; 1,515 visitor controls) in Mumbai, India, during the years 2009-2013. Extensive questionnaire data, anthropometry measurement and blood samples were collected on all participants.
Semin Oncol
October 2015
Department of Human Oncology, Pittsburgh Campus of Temple University School of Medicine, Pittsburgh, PA.
Large cancer prevention trials provide opportunities to collect a wide array of data and biospecimens at study entry and longitudinally, for a healthy, aging population without cancer. This provides an opportunity to use pre-diagnostic data and specimens to evaluate hypotheses about the initial development of cancer. We report on strides made by, and future possibilities for, the use of accessible biorepositories developed from precisely annotated samples obtained through large-scale National Cancer Institute (NCI)-sponsored cancer prevention clinical trials conducted by the NCI Cooperative Groups.
View Article and Find Full Text PDFOncologist
June 2015
National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China; Center for Global Health, U.S. National Cancer Institute, Rockville, Maryland, USA; Center for Global Health and Center for Chronic Disease Prevention and Health Promotion, Division of Cancer Control and Prevention, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Introduction: Cervical cancer is one of the most commonly diagnosed cancers among women in China. The World Health Organization (WHO) recommends routine screening for cervical cancer, and the WHO Global Monitoring Framework suggests that every nation monitors cervical cancer screening. However, little information is available on cervical cancer screening behavior among women in China.
View Article and Find Full Text PDFHealth Phys
May 2015
*Radiation Effects Research Foundation, Hiroshima, Japan; †Tokyo Healthcare University, Tokyo, Japan; ‡U.S. National Cancer Institute, Bethesda, MD; §National Institute of Radiological Sciences, Chiba, Japan; **Fukushima Medical University, Fukushima, Japan; ††Hirosoft, Eureka, CA; ‡‡Osaka University, Osaka, Japan; §§University of Manchester, Manchester, UK.
The RERF International Low-Dose Symposium was held on 5-6 December 2013 at the RERF campus in Hiroshima, Japan, to discuss the issues facing the Life Span Study (LSS) and other low-dose studies. Topics included the current status of low-dose risk detection, strategies for low-dose epidemiological and statistical research, methods to improve communication between epidemiologists and biologists, and the current status of radiological studies and tools. Key points made by the participants included the necessity of pooling materials over multiple studies to gain greater insight where data from single studies are insufficient; generating models that reflect epidemiological, statistical, and biological principles simultaneously; understanding confounders and effect modifiers in the current data; and taking into consideration less studied factors such as the impact of dose rate.
View Article and Find Full Text PDFPLoS One
December 2015
Gretchen Swanson Center for Nutrition, Omaha, Nebraska, United States of America.
Background: Low fruit and vegetable (FV) intake is a leading risk factor for chronic disease globally as well as in the United States. Much of the population does not consume the recommended servings of FV daily. This paper describes the development of psychosocial measures of FV intake for inclusion in the U.
View Article and Find Full Text PDFHealth Phys
March 2014
*State Institution "National Research Centre for Radiation Medicine," National Academy of Medical Sciences of Ukraine, 53 Melnikova Street, 04050 Kyiv, Ukraine; †Institute for Safety Problems of Nuclear Power Plants, National Academy of Sciences of Ukraine, 12/106 Lysogirska Street, 03028 Kyiv, Ukraine; ‡MJP Risk Assessment, Inc., P.O. Box 200937, Denver, CO 80220-0937; §Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 9609 Medical Center Drive, Bethesda, MD 20892; **U.S. National Cancer Institute (retired).
In collaboration with the Ukrainian Research Center for Radiation Medicine, the U.S. National Cancer Institute initiated a cohort study of children and adolescents exposed to Chornobyl fallout in Ukraine to better understand the long-term health effects of exposure to radioactive iodines.
View Article and Find Full Text PDFBiopreserv Biobank
April 2013
U.S. National Cancer Institute, Bethesda, Maryland.
Global methylation in blood DNA has been associated with bladder cancer risk in case-control studies, but has not been examined prospectively. We examined the association between LINE1 total percent 5-methylcytosine and bladder cancer risk using pre-diagnostic blood DNA from the United States-based, Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial (PLCO) (299 cases/676 controls), and the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) cohort of Finnish male smokers (391 cases/778 controls). Logistic regression adjusted for age at blood draw, study center, pack-years of smoking, and sex was used to estimate odd ratios (ORs) and 95% confidence intervals (CIs) using study- and sex-specific methylation quartiles.
View Article and Find Full Text PDFBiopreserv Biobank
October 2012
1 Office of Division Operations and Analysis, Division of Cancer Epidemiology and Genetics, U.S. National Cancer Institute, NIH, DHHS, Bethesda, Maryland, USA .
Cancer Prev Res (Phila)
January 2010
Cancer Biomarkers Research Group, Division of Cancer Prevention, U.S. National Cancer Institute, Rockville, MD 20852, USA.
Although the potential of biomarkers to aid in the early detection, diagnosis, prevention, and treatment of breast cancer is broadly recognized and numerous biomarker candidates have been reported in the literature, few molecular markers have been adopted into clinical use to date. To address this lack of translation of biomarkers from the bench to clinical practice, the Cancer Biomarkers Research Group in the Division of Cancer Prevention of the National Cancer Institute organized a meeting, "Strategic Discussion on Biomarkers for Breast Cancer," which was held at the Fred Hutchinson Cancer Research Center on September 14, 2008. Participants included industry leaders, basic and physician scientists, and National Cancer Institute program staff.
View Article and Find Full Text PDFExp Oncol
June 2006
Biometric Research Branch, DCTD, U.S. National Cancer Institute, Bethesda,MD 20892, USA.
Despite years of research and hundreds of reports on tumor markers in oncology, the number of markers that have emerged as clinically useful is pitifully small. Often, initially reported studies of a marker show great promise, but subsequent studies on the same or related markers yield inconsistent conclusions or stand in direct contradiction to the promising results. It is imperative that we attempt to understand the reasons that multiple studies of the same marker lead to differing conclusions.
View Article and Find Full Text PDFBMC Cancer
August 2005
U.S. National Cancer Institute, Cancer Diagnosis Program, Bethesda, USA.
Background: For over 150 years, pathologists have relied on histomorphology to classify and diagnose neoplasms. Their success has been stunning, permitting the accurate diagnosis of thousands of different types of neoplasms using only a microscope and a trained eye. In the past two decades, cancer genomics has challenged the supremacy of histomorphology by identifying genetic alterations shared by morphologically diverse tumors and by finding genetic features that distinguish subgroups of morphologically homogeneous tumors.
View Article and Find Full Text PDFDNA Cell Biol
October 2001
Laboratory of Metabolism, U.S. National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
We characterized the mouse metastasis-associated gene 2 product (mmta2), which is a homolog of the metastasis-associated gene 1 product (MTA1). We revealed that the mmta2 gene spanned approximately 10 kb and was separated into 18 exons. The transcription start site of mmta2 was located 377 bp upstream from the putative initiation codon.
View Article and Find Full Text PDF